What is the FDA doing to help ensure the safety of imported infant formula?

FDA Webinar on New Infant Formula Transition Plan (Part 2)

FDA Expert Panel on Testosterone Replacement Therapy for Men

Medical Device Quality Management System Regulation Risk Management

FDA Grand Rounds - Statistical Considerations for Drug Development in Rare Disease

FDA Grand Rounds - Postmarket Regulation of Cosmetic Products: The Who, What, When, Why, and How

FDA Grand Rounds - Anti biofilm Technologies for Enhancing the Safety of Medical Device Surfaces

FDA-USP-AAM | D1S3 - Industry’s Engagement in USP’s Standards-Setting Process

FDA Grand Rounds - Advancing Real World Evidence in FDA Regulatory Decision Making

FDA Grand Rounds - Adopting Large Language Models for Regulatory Review

Conversations on Cancer – Perspectives on Cancer Care Decision-Making Among Older Adults

FDA Grand Rounds - Antibody Glycosylation Insights for High Quality Biotherapeutics

Medical Device Quality Management System Regulation Design and Development

Public Meeting: Reauthorization of the Biosimilar User Fee Act

FDA-USP-AAM | D1S1 – FDA's Participation in USP-NF Revision Process – Challenges and Solutions

FDA Grand Rounds - Forensic Proteomics Applied to FDA Regulated Products

FDA Celebrates 120 Years

FDA-USP-AAM | D1S2 – Strengthening Your Compendial Strategy

2025 FDA Achievements

FDA-USP-AAM | D1S4 – Q&A Discussion Panel

Does FDA have any tips on preparing powdered formula coming from other countries?